UK markets closed

Santen Pharmaceutical Co Ltd (SZD.HA)

Hanover - Hanover Delayed price. Currency in EUR
Add to watchlist
9.45+0.05 (+0.53%)
At close: 08:08AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/03/2024
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Cash flows from operating activities
Net income
26,642,000
26,642,000
-14,948,000
27,218,000
9,311,000
-
Depreciation & amortisation
18,178,000
18,178,000
17,249,000
17,055,000
17,498,000
-
Change in working capital
14,168,000
14,168,000
-5,650,000
1,180,000
-21,477,000
-
Inventory
-1,369,000
-1,369,000
-1,144,000
5,383,000
-4,590,000
-
Other working capital
61,962,000
61,962,000
12,559,000
10,202,000
15,004,000
-
Other non-cash items
7,059,000
7,059,000
1,946,000
22,000
2,384,000
-
Net cash provided by operating activities
72,649,000
72,649,000
37,147,000
46,043,000
38,808,000
-
Cash flows from investing activities
Investments in property, plant and equipment
-10,687,000
-10,687,000
-24,588,000
-35,841,000
-23,804,000
-
Acquisitions, net
-207,000
-207,000
-3,470,000
-2,969,000
-29,183,000
-
Purchases of investments
-301,000
-301,000
-589,000
-1,067,000
-3,384,000
-
Sales/maturities of investments
4,127,000
4,127,000
2,149,000
3,870,000
3,070,000
-
Other investing activities
127,000
127,000
-279,000
838,000
-54,000
-
Net cash used for investing activities
-6,145,000
-6,145,000
-26,777,000
-35,169,000
-53,355,000
-
Net change in cash
32,473,000
32,473,000
-26,850,000
16,432,000
-31,232,000
-
Cash at beginning of period
57,903,000
57,903,000
83,014,000
62,888,000
91,430,000
-
Cash at end of period
94,582,000
94,582,000
57,903,000
83,014,000
62,888,000
-
Free cash flow
Operating cash flow
72,649,000
72,649,000
37,147,000
46,043,000
38,808,000
-
Capital expenditure
-10,687,000
-10,687,000
-24,588,000
-35,841,000
-23,804,000
-
Free cash flow
61,962,000
61,962,000
12,559,000
10,202,000
15,004,000
-